App Store

Google Play

{{seriesTitle}} - Seria książek

PL - Details page - Device banner - 894x1036

Witaj w nieskończonym świecie literatury

Słuchaj i czytaj

Frontiers in Clinical Drug Research - Dementia is a book series which presents comprehensive reviews about research on Dementia, - the loss of brain function associated with Alzheimer’s diseases and other related conditions. The disease affects the parts of the brain that deal with memory, thought, and language. Chapters in each volume focus on drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for dementia and related disorders.

This volume includes the following reviews:
- Meeting the Challenges of Falls and Hip Fractures in People with Alzheimer’s Disease
- Cholesterol in Brain Health and Pathologies
- Advances in Treatment of Mild Cognitive Impairment (MCI) and Dementia
- Analytical Methods in Alzheimer’s Disease Drug Discovery
- Targeting Alzheimer’s Disease through Nanomedicine
- Current Challenges in Alzheimer’s Disease Research
- Metals Linked to Alzheimer's Disease

Frontiers in Clinical Drug Research - Dementia will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in field.

Bentham Science

Frontiers in Clinical Drug Research - Dementia

Frontiers in Clinical Drug Research

Among neurodegenerative diseases, those that lead to a state ofdementia are the aim of severalinvestigations. Dementia is a chronic disease the prevalence of whichis increasing worldwide. Thenumber of dementia patients in the world is approximately 50 million,and it is estimated that thenumber of patients will reach 131.5 million by 2050. This increase willbe accompanied by asignificant increase in medical expenditures and other expenses,especially for elderly patients.Therefore, the maintenance cost of dementia in the future is expectedto be quite high. For thisreason, several investigations aim, firstly, to describe the keymechanisms involved in the originof dementia and, secondly, to establish preventive and therapeuticstrategies in order tounderstand and mitigate this debilitating pathology. This volume of Frontiers in Clinical Drug Research -Dementia explores the current comorbidities that cause cognitiveimpairment and the current management alternatives for clinical cases ofdementia. The reviews contributed in these volume will provide readers with acurrent perspective on the subject. The topics covered in this volume include:- Comorbidities inducing mild cognitive impairment - an evaluation ofthe risk caused by some pathological conditions- Tau-targeted therapy in Alzheimer's disease - history and currentstate- Emerging nanotherapeutic strategies in Alzheimer's disease- Implication of dehydroepiandrosterone on dementia related tooxidative stress- Polyphenol compounds as potential therapeutic agents in Alzheimer’sdisease The volume is a timely update on dementia treatment for clinicalphysicians, neurologists, gerontologists, pharmaceutical and medicinal chemistryresearchers, and physiologists.

Frontiers in Clinical Drug Research - Dementia - Seria książek

Frontiers in Clinical Drug Research - Dementia - Seria książek

Frontiers in Clinical Drug Research - Dementia książki w kolejności

Słuchaj i czytaj